SAMSUNG PHARM. Co., LTD. (KRX:001360)
South Korea · Delayed Price · Currency is KRW 1,245.00
+6.00 (0.48%)
At close: Aug 3, 2026
SAMSUNG PHARM. Co., LTD. Market Cap
SAMSUNG PHARM. Co., LTD. has a market cap or net worth of 117.18 billion as of August 3, 2026. Its market cap has decreased by -19.47% in one year.
Market Cap
117.18B
Enterprise Value
n/a
Revenue
44.29B
Ranking
n/a
PE Ratio
9.22
Stock Price
1,245.00
ChartMarket Cap Chart
Since August 31, 1995, SAMSUNG PHARM. Co., LTD.'s market cap has increased from 17.88B to 117.18B, an increase of 555.19%. That is a compound annual growth rate of 6.26%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 3, 2026 | 117.18B | -18.63% |
| Dec 30, 2025 | 144.00B | -0.52% |
| Dec 30, 2024 | 144.76B | -0.84% |
| Dec 28, 2023 | 145.99B | -18.99% |
| Dec 29, 2022 | 180.22B | -45.48% |
| Dec 30, 2021 | 330.57B | -11.17% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hyundai Pharmaceutical | 148.35B |
| Ilsung Is | 140.08B |
| Jeil Pharmaceutical Co.,Ltd | 137.41B |
| Samil Pharmaceutical Co.,Ltd | 132.50B |
| Dongwha Pharm.Co.,Ltd | 129.72B |
| AptaBio Therapeutics | 129.09B |
| Kyongbo Pharmaceutical | 121.69B |
| HANDOK | 115.10B |